Article Versions Notes

Diefenhardt M, Martin D, Ludmir EB, Fleischmann M, Hofheinz R-D, Ghadimi M, Kosmala R, Polat B, Friede T, Minsky BD, et al. Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers. 2022; 14(18):4425. https://doi.org/10.3390/cancers14184425

Diefenhardt, Markus, Daniel Martin, Ethan B. Ludmir, Maximilian Fleischmann, Ralf-Dieter Hofheinz, Michael Ghadimi, Rebekka Kosmala, Bülent Polat, Tim Friede, Bruce D. Minsky, and et al. 2022. "Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial" Cancers 14, no. 18: 4425. https://doi.org/10.3390/cancers14184425

Diefenhardt, M., Martin, D., Ludmir, E. B., Fleischmann, M., Hofheinz, R. -D., Ghadimi, M., Kosmala, R., Polat, B., Friede, T., Minsky, B. D., Rödel, C., & Fokas, E. (2022). Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers, 14(18), 4425. https://doi.org/10.3390/cancers14184425